Rathod, an IP professional attached to a global generic pharmaceutical company, draws hundreds of readers from across the IP space to his genericpharmaceuticals.blogspot.com.
What we need is some informed debate on what is India's best interest at this particular stage instead of going for a wholesale import of an American system that could prove ineffectual.